AGM Information • Apr 20, 2021
AGM Information
Open in ViewerOpens in native device viewer
In order to be valid, this proxy must reach, duly completed, dated and signed, MITHRA PHARMACEU-TICALS SA no later than May 14th , 2021, as described in the convening notice. This proxy can be sent by regular mail to the address of the registered office of the company or by fax or by e-mail (see useful information hereafter). Proxies arriving late or not complying with the required formalities may be rejected.
First Name, Last name /name of the company: (please complete)
(for legal persons) represented by: (please complete)
Residing at/having its registered office at: (please complete)
Owner of (please complete)…………………….. shares of Mithra Pharmaceuticals SA, with registered office at rue Saint-Georges 5, 4000 Liège,
hereby appoints as a proxy holder:
First Name, Last name/name of the company: Rozenberg Fanny, Rue Robert 28 à 4340 Othée, Corporate Secretary de la Société, (with full power of substitution) ;
Due to the measures taken by our governments and public authorities restricting gatherings in the framework of the CoViD-19, the proxies will exclusively be given to Mrs. Fanny Rozenberg.
In order to:
A. Represent him/her/it at Mithra Pharmaceuticals SA's Ordinary and Extraordinary General Meetings that will be held on May 20th , 2021, 2 p.m. at Mithra CDMO, rue de l'Expansion 57 à 4400 Flémalle (Belgium) and to vote in his/her/its name on all the items on the following agenda in the manner described. Lacking instructions on how to vote or abstain for one or more of the decisions proposed below or if for any reason the instructions given are not clear, please consider that this is a specific instruction to vote in favor of the proposed resolutions.
Proposed resolution: The General Meeting approves the non-consolidated annual accounts closed on the 31 December 2020.
FOR AGAINST ABSTAIN
5. Allocation of the results relating to the financial year ended 31 December 2020;
Proposed resolution: The General Meeting approves the allocation of the results reflected in the annual accounts for the financial year ended 31 December 2020.
FOR AGAINST ABSTAIN
Proposed resolution: The General Meeting approves the remuneration report related to the financial year closed on 31 December 2020.
FOR AGAINST ABSTAIN
Proposed resolution: The General Meeting grants special discharge of liability to the statutory auditor for the performance of his mandate during the financial year closed on 31 December 2020.
8. Proposal to grant discharge of liability to the board of Directors, including directors who resigned during the 2020 financial year;
Proposed resolution: The General Meeting grants, by separate vote, discharge to each of the Directors for the performance of their respective mandate during the financial year closed on 31 December 2020.
1.- AHOK SRL., represented by Mr Koen Hoffman, a company registered under the law of Belgium, located Steenvoordestraat 166 in 9070 Destelbergen, Heusden and registered in B.C.E. under number 0457.927.595;
FOR AGAINST ABSTAIN
2.- ALYCHLO N.V., represented by Mr Marc Coucke, a company registered under the law of Belgium, located Lembergsteenweg 19 in 9820 Merelbeke and registered in B.C.E. under number 0895.140.645;
FOR AGAINST ABSTAIN
3.- AUBISQUE SRL, represented by Ms. Freya Loncin, a company registered under the law of Belgium, located Vlaamsekunstlaan 38 in 2020 Antwerpen and registered in B.C.E under number 0843.087.970;
FOR AGAINST ABSTAIN
4.- CG CUBE SRL, represented by Mr Guy Debruyne, a company registered under the law of Luxembourg, located Route d'Arlon 96 à 8210 Mamer (GDL);
FOR AGAINST ABSTAIN
5.-- EVA CONSULTING SRL, represented by Mr Jean-Michel Foidart, a company registered under the law of Belgium, located sur la Heid 3 in 4870 Trooz and registered in B.C.E. under number 0874.027.804;
FOR AGAINST ABSTAIN
6.- YIMA SRL, represented by Mr. François Fornieri, a company registered under the law of Belgium, located rue Saint Georges 5 à 4000 Liège and registered in B.C.E. under the number 0871.523.818;
FOR AGAINST ABSTAIN
7.- NOSHAQ SRL, represented by Mr Gaëtan Servais, a company registered under the law of Belgium, located rue Lambert Lombard 3, Hôtel Copis à 4000 Liège and registered in B.C.E. under number 0426.624.509;
8.- CASTORS DEVELOPMENT SA, represented by J. Platieau, a company registered under the law of Belgium, located Chaussée d'Alsemberg 421, box A14 in 1420 Braine-L'Alleud;
FOR AGAINST ABSTAIN
9.- P. SUINEN SRL, represented by Mr Philippe Suinen, a company registered under the law of Belgium, located Rond-Point Hanon 1 in 6230 Pont-à-Celles and registered in B.C.E. under number 0553.961.555.;
FOR AGAINST ABSTAIN
10.- P4Management BVBA, represented by Ms. Christiane Malcorps, a company registered under the law of Belgium, located Merodestraat 9 à 1850 Grimbergen and registered in B.C.E. under the number 0667.907.950;
FOR AGAINST ABSTAIN
11.- SELVA Luxembourg SA, represented by Mr Christian Moretti, a company registered under the law of Luxembourg, located Guillaume Kroll street 3 in 1882 Luxembourg (GDL);
FOR AGAINST ABSTAIN
12.-NOSHAQ PATNER SCRL, represented by Ms. Joanna Tyrekidis, a company registered under the law of Belgium, located rue Lambert Lombard 3, Hôtel Copis à 4000 Liège and registered in B.C.E. under the number 0808.219.836.;
FOR AGAINST ABSTAIN
13.- Ms. Patricia Van Dijck, domiciled Boulevard Général Wahis 39 à 1030 Brussels ;
FOR AGAINST ABSTAIN
14.- Sunathim SRL, represented by Mr. Ajit Shetty, a company registered under the laws of Belgium, located at Wielewaalstraat 18, 2350 Vosselaar, registered in BCE under number 0871.523.818;
15.- TicaConsult SRL, represented by Mr. Erik van den Eynden, a company registered under the laws of Belgium, located at Kapelaan Smitslaan 20, 2650 Edegem, registered in BCE under number 0636 809 156;
FOR AGAINST ABSTAIN
Proposed resolution: The General Meeting approves, with immediate effect, the renewal of these directors:
FOR AGAINST ABSTAIN
FOR AGAINST ABSTAIN
FOR AGAINST ABSTAIN
YIMA SRL, represented by Mr. François Fornieri, a company registered under the law of Belgium, located rue Saint Georges 5 à 4000 Liège and registered in B.C.E. under the number 0871.523.818 as a non-executive director;
NOSHAQ SRL, represented by Mr Gaëtan Servais, a company registered under the law of Belgium, located rue Lambert Lombard 3, Hôtel Copis à 4000 Liège and registered in B.C.E. under number 0426.624.509 as a non-executive director;
FOR AGAINST ABSTAIN
FOR AGAINST ABSTAIN
Proposed resolution: The General Meeting decides to appoint Mrs. Amel Tounsi, residing at Place Jean Gabin 1, 1090 Jette, as a non-executive director of the Company, for a period of two years, until and including the closing of the Ordinary General Meeting to be held in 2023 and which will have ruled on the annual accounts for the financial year ending on December 31, 2022.
FOR AGAINST ABSTAIN
Proposed resolution: The General Meeting decides to appoint Mrs. An Cloet as independent director of the Company within the meaning of article 7:87 of the Companies and Associations Code and provision 3.5 of the Belgian Corporate Governance Code 2020, for a term of two years, until and including the closing of the Ordinary General Meeting to be held in 2023 and which will have ruled on the annual accounts of the financial year ending on December 31, 2022.
Proposed resolution: The Shareholders' Meeting decides to appoint Mrs. Liesbeth Weynants as independent director of the Company within the meaning of article 7:87 of the Companies and Associations Code and provision 3.5 of the Belgian Corporate Governance Code 2020, for a term of two years, until and including the closing of the Ordinary General Meeting to be held in 2023 and which will have ruled on the annual accounts of the financial year ending on December 31, 2022.
FOR AGAINST ABSTAIN
Proposed resolution: The Shareholders' Meeting decides to appoint SRL ALIUS MODI, represented by its permanent representative, Mrs. Valérie Gordenne, having its registered office at Bèfve 22, 4890 Thimister-Clermont and registered with the ECB under number 0809.631.185, as non-executive director of the Company, for a term of two years, until and including the closing of the Ordinary General Meeting to be held in 2023 and which will have ruled on the financial statements of the fiscal year ending on December 31, 2022.
FOR AGAINST ABSTAIN
Proposed resolution : The General Meeting, based on the Audit Committee's recommendation and of the Board of Directors, decides to renew the mandate of SCRL BDO Réviseurs d'entreprises (approval B00023) as statutory audiotor, having its registered office at 4651 Battice, rue Waucomont 51, duly represented by Mr. Cédric Antonelli, auditor (approval A 02203) in its quality of permanent representative for a three years term with immediate effect and until and including the close of the Ordinary General Meeting to be held in 2024 to approve the financial statements for the fiscal year ending December 31, 2023.
FOR AGAINST ABSTAIN
Proposed resolution: In accordance with article 7:89/1 of the Companies and Associations Code, the General Assembly approves the remuneration policy presented by the Board of Directors.
FOR AGAINST ABSTAIN
16. Approval of a change of control provision in accordance with Article 7: 151 of the Belgian Companies and Associations Code;
Proposed resolution: The General Meeting takes note of, approves and ratifies in accordance with article 7: 151 of the Companies and Associations Code, all clauses of the Conditions of the 4.250 percent convertible bonds issued by the Company on December 17, 2020, maturing on December 17, 2025 (ISIN BE6325746855), which take effect at the time a change of control occurs, including, but not limited to, Conditions 5(b)(x) and 6(d) and which fall or could be considered to fall within the scope of Article 7: 151 of the Companies and Associations Code relating to the granting of rights to third parties which substantially affect the assets of the Company or give rise to a substantial debt or liability on its part, where the exercise of such rights is dependent on the launch of a public takeover bid for the shares of the Company or a change of control over it. The Shareholders' Meeting also grants a special power of attorney to each director of the Company and to Mr. Cédric Darcis (legal manager) (each a "Mandatary"), each Mandatary acting alone and with the right of substitution, to carry out the formalities required by Article 7:151 of the Belgian Code of Companies and Associations with respect to this decision, including, but not limited to, the execution of all documents and forms required for the publication of this decision in the Annexes to the Belgian Official Gazette.
FOR AGAINST ABSTAIN
Proposed resolution: The Shareholders' Meeting decides to approve the renewal of the authorization given to the Board of Directors to increase the capital on one or more occasions, during a period of five (5) years as from the publication in the Annexes to the Belgian Official Gazette of the present authorization, by a total amount up to 100% of the amount of the share capital of the Company, and this in accordance with the terms and conditions set forth in the special report of the Board of Directors prepared in accordance with Article 7:199 of the Companies and Associations Code, as referred to in item 1. of the agenda of the present Extraordinary General Meeting. Accordingly, the Shareholders' Meeting resolves to delete Article 7 A. of the Company's Articles of Association and to replace it with the following text (the date mentioned in the sub-section in square brackets being the date of the Shareholders' Meeting approving the renewed authorized capital, and the amount mentioned in the sub-section in square brackets being the amount of the Company's share capital at the time of the Shareholders' Meeting approving the authorized capital).
" A. The Board of Directors is authorized to increase the capital in one or more transaction within the limits set by law, in particular by issuing convertible bonds and subscription rights, up to a maximum amount of [100% of the Company's capital at the time of adoption of the new authorized capital]. The board of directors is expressly authorized to use this authorization for the following operations:
- Capital increases or issues of convertible bonds or subscription rights with cancellation or limitation of the preferential subscription rights of the existing shareholders;
- The capital increases or the issuance of convertible bonds or subscription rights with cancellation or limitation of the preferential subscription rights of the existing shareholders for the benefit of one or more specific persons who are not part of the personnel of the Company or its subsidiaries;
- Capital increases carried out by incorporation of reserves.
Any such capital increase may take any and all forms ,including but not limited to, contributions in cash or in kind, with or without share premium, as well as by incorporation of reserves and/or share premium and/or profits carried forward, to the maximum extent permitted by the law. This authorization is granted to the Board of Directors for a period of five (5) years as from the date of publication in the Annexes to the Belgian Official Gazette of an extract from the minutes of the General Meeting of [date of the Extraordinary General Meeting approving the renewal of the authorized capital]."
FOR AGAINST ABSTAIN
"B. The Board of Directors is expressly authorized to make use of the authorization granted under A. even after the Company has received notification from the Authority for Financial Services and Markets that it has received a notice of a public takeover bid for the Company, under the mandatory conditions set forth in Article 7:202 of the Companies and Associations Code. This authorization is granted to the Board of Directors for a period of three (3) years as from the General Meeting of [date of the Extraordinary General Meeting approving the renewal of the authorized capital]. It is renewable."
FOR AGAINST ABSTAIN
***
Provided he/she/it has completed the formalities referred to in the convening notice to that effect, and unless otherwise instructed, the undersigned notes that he/she/it will be represented at the Ordinary General Meetings for the total number of shares it owns in the shareholders register or has notified the ownership on the record date at midnight (Belgian time), on 06 May 2021.
If requests for the addition of new items to the agenda, and/or submits of new motions for a resolution relating to items on the agenda or to be added to the agenda are added at shareholders' request in compliance with article 7:130 of the Belgian Companies Code, the proxy holder is authorized, in compliance with article 7:130, §4, al.2 of the Belgian Companies Code, to withdraw from any possible instructions given by the shareholder if the execution of these instructions risks compromising the interest of the shareholder.
If, after the date of this proxy form, new items are added to the agenda, or new motions for a resolution relating to items on the agenda or to be added to the agenda are added at the request of shareholders in compliance with article 7:130 of the Companies Code, the proxy holder:
is authorized to vote (*);
must abstain from voting (*).
(*) Cross out the option not chosen. If none is crossed out, the proxy holder will have to abstain from voting on the new items added to the agendas.
B. to take part in all discussions on the items listed on the agenda for this meeting, to cast all votes, to pass and sign all acts, items, minutes, attendance lists and other documents:
C. in general, do all that is necessary to carry out this proxy, promising ratification in advance.
D. The undersigned hereby undertakes to indemnify the proxies for any liability which they may incur in relation to any act carried out for the purposes of implementing this proxy, provided the proxies have respected the scope of their powers. Moreover, the undersigned undertakes not to seek the nullity of any resolution approved by the proxies and not to seek damages from the proxies, provided the proxies have respected the scope of their powers.
Signed in……………………………………………………….., on………………………………………………………………….
Signature(s) must be preceded by the hand-written words "Good for proxy"
Useful Information Mithra Pharmaceuticals SA Assemblée Générale 5 rue Saint-Georges 4000 Liège Fax : +32(0)4.349.28.21 E-mail : [email protected] Site internet : www.mithra.com
We would appreciate if you could provide us with a telephone number and an e-mail address where we can reach you if necessary,to validate this proxy and/or to provide you with additional information relating to the General Meeting:
Tel: ………………………………………………………………………………………………………………
E-mail: …………………………………………………………………………………………………………1
1 Your personal data will be processed in accordance with our Company's Privacy Policy, as published on our website
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.